Transcutaneous auricular vagus nerve stimulation (taVNS) reduces postpartum blues severity after cesarean delivery
A 5-day taVNS intervention significantly reduced postpartum blues severity on day 5, as measured by a visual analogue scale (median difference 4.13 cm; 95% CI, 3.39-4.93; p < 0.001). The active group also showed lower rates of Edinburgh Postnatal Depression Scale scores ≥13 at 1 month postpartum (4% vs. 26%; p = 0.003) and improved sleep quality on postoperative days 1-4.
This article is automatically generated from the structured evidence profile behind the claim above. Scores reflect the quality and quantity of available research, not clinical advice.
Transcutaneous auricular vagus nerve stimulation (taVNS) reduces postpartum blues severity after cesarean delivery The current body of evidence comprises 1 study, including 1 randomized controlled trial. EvidenceHub rates the overall confidence at 44/100 (low).
The Claim
Transcutaneous auricular vagus nerve stimulation (taVNS) reduces postpartum blues severity after cesarean delivery
This conclusion is most relevant to: 100 women following cesarean delivery.
What the Research Shows
The conclusion draws on 1 linked study. Highlights from the cited literature:
- ▸Effectiveness of transcutaneous auricular vagus nerve stimulation in alleviating postpartum blues following cesarean delivery: A randomized double-blind controlled trial. (Journal of affective disorders, 2026) —
How It Works
The proposed biological pathway:
- ▸taVNS activates vagus nerve afferents via auricular branch
- ▸Modulates central autonomic and mood-regulating circuits
- ▸Reduces inflammatory and stress responses
- ▸Result: Decreased postpartum blues severity and improved mood
Who Might Benefit
Evidence fit by population:
- ▸100 women following cesarean delivery
Recommended Dose
5 days of taVNS (specific stimulation parameters not reported in abstract)
Limitations & Caveats
Important context when interpreting this evidence:
- ▸Specific stimulation parameters (e.g., frequency, intensity) not detailed in abstract
- ▸Single-center trial may limit generalizability
- ▸Sham control may not fully blind participants due to potential sensory differences
Frequently Asked Questions
What is taVNS?▼
Transcutaneous auricular vagus nerve stimulation is a non-invasive technique that stimulates the vagus nerve through electrodes placed on the ear.
How long was the taVNS treatment given?▼
The intervention was applied over 5 days following cesarean delivery.
Did taVNS affect depression rates at one month?▼
Yes, only 4% of the active group had Edinburgh Postnatal Depression Scale scores ≥13 at 1 month compared to 26% in the sham group.
Was sleep quality improved?▼
Yes, sleep quality assessed by the Richards-Campbell Sleep Questionnaire was significantly improved on postoperative days 1 to 4.
References
- 1.Cheng Q, Lu M, Chen Y, Han Q, Du R, Yang W, Huang X, Zhang Y, Li J, Zhang J, Yu X. “Effectiveness of transcutaneous auricular vagus nerve stimulation in alleviating postpartum blues following cesarean delivery: A randomized double-blind controlled trial..” Journal of affective disorders, 2026. PMID: 42462365 DOI: 10.1016/j.jad.2026.122256